Chemomab Therapeutics Ltd. (CMMB) Financials

$1.16

$0.01 (0.87%)
Last update: 01:00 PM EST
Day's range
$1.16
Day's range
$1.19
$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

CMMB Income statement / Annual

Last year (2024), Chemomab Therapeutics Ltd.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Chemomab Therapeutics Ltd.'s net income was -$13.95 K. See Chemomab Therapeutics Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $53.25 K $66.83 K $57.77 K $34.02 K $80.00 K $281.91 K $66.00 K $51.00 K $40.64 K $26.25 K
Gross Profit $0.00 -$66.83 K -$57.77 K -$34.02 K -$80.00 K -$282.00 K -$65.79 K -$51.00 K -$40.64 K -$26.25 K
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $11.33 K $18.38 M $16.98 M $6.33 M $4.68 M $13.35 M $7.51 M $6.23 M $2.34 M $5.97 M
General & Administrative Expenses $3.41 K $7.08 M $11.56 M $6.03 M $1.29 M $6.25 M $5.49 M $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $3.41 K $7.08 M $11.56 M $6.03 M $1.29 M $5.98 M $5.46 M $3.11 M $2.25 M $1.14 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $749.00 K $3.35 M $0.00 $0.00 $0.00 $0.00
Operating Expenses $14.74 K $25.46 M $28.53 M $12.37 M $5.97 M $19.33 M $12.97 M $9.34 M $4.59 M $7.11 M
Cost And Expenses $14.74 K $25.46 M $28.53 M $12.37 M $5.97 M $19.61 M $13.04 M $9.39 M $4.63 M $7.13 M
Interest Income $797.77 K $1.24 M $351.62 K $65.00 $20.00 K $393.00 K $0.00 $1.00 K $521.00 $1.03 K
Interest Expense $0.00 $0.00 $353.00 K $111.08 K $6.00 K $9.00 K $0.00 $5.00 K $0.00 $14.16 K
Depreciation & Amortization $53.25 K $67.00 K $57.77 K $34.02 K $80.00 K $281.91 K $66.00 K $51.00 K $40.64 K $26.25 K
EBITDA -$14.67 K -$25.39 M -$28.48 M -$12.33 M -$5.95 M -$26.92 M -$13.36 M -$9.50 M -$4.57 M -$7.46 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $794.00 K $1.24 M $353.00 K -$111.00 K $21.00 K -$7.60 M -$456.00 K -$91.71 K $36.33 K -$369.00 K
Income Before Tax -$13.95 K -$24.22 M -$28.18 M -$12.48 M -$5.95 M -$27.21 M -$5.87 M -$9.56 M -$4.61 M -$7.50 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$534.00 K $77.00 K -$21.00 K $0.00 $306.00 K $323.00 K $136.24 K -$3.00
Net Income -$13.95 K -$24.22 M -$27.65 M -$12.48 M -$5.95 M -$27.21 M -$13.80 M -$9.81 M -$4.73 M -$7.50 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -0.78 -2.06 -2.42 -1.2 -6.3 -15.8 -21.77 -219 -17.25 -32.94
EPS Diluted -0.78 -2.06 -2.42 -1.2 -6.3 -15.8 -21.77 -219 -17.25 -32.94
Weighted Average Shares Out $17.95 M $11.75 M $11.38 M $10.37 M $1.85 M $1.72 M $631.70 K $45.13 K $271.67 K $227.69 K
Weighted Average Shares Out Diluted $17.95 M $11.75 M $11.38 M $10.37 M $1.85 M $1.72 M $631.70 K $45.13 K $271.67 K $227.69 K
Link